Tablet Tooling Coating Reduces Formulation Sticking

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-12-02-2013
Volume 37
Issue 12

Tablet Tooling Coating Reduces Formulation Sticking

PharmaCote CX and CX+,  an enhanced Chromium Nitride, are a range of coatings developed to improve the performance of substrate material for punches and dies. The coating offers a smooth finish and anti-stick performance, the company reports. PharmaCote CX provides prolonged tooling life due to a multi-layered application. It also offers up to 13 times more corrosion resistance than PharmaCote HC (Hard Chromium) and up to two times the life of PharmaCote CN (Chromium Nitride).

I Holland

Articles in this issue
Rail-Mounted Fluid Bed Dryers Allow Cleaning Access
Biotechnology Innovation and Growth in Israel
Biotechnology Innovation and Growth in Israel
NEW_SiegfriedSchmitt_New-830192-1408530638094.jpg
Drug Manufacturing Focus: Why India?
Milmo_Sean-830460-1408530369145.jpg
Regulation of Biosimilars: A Matter of Variability, Similarity, and Comparability
Clinical Trials Head East to Asia
Clinical Trials Head East to Asia
Miller_Jim-830183-1408530640566.jpg
Climate Change in Outsourcing
Deficiencies Found in API Inspections
Q&A with Brian Galliher, Cook Pharmica
Q&A with Brian Galliher, Cook Pharmica
Smith_Tim-830428-1408530412176.jpg
Inspiring the Next Generation
Establishing a Minimum Incubation Time for Biological Indicators
Establishing a Minimum Incubation Time for Biological Indicators
Implementing QbD in Sterile Manufacturing
Implementing QbD in Sterile Manufacturing
Wechsler_Jill-830087-1408530742383.jpg
Opioid Regulation Challenges FDA and Manufacturers
NEW_Schenck-830505-1408530288927.jpg
Low Feed Rate Feeder Designed for Pharmaceutical Processes
NEW_IHolland-830502-1408530294595.jpg
Tablet Tooling Coating Reduces Formulation Sticking
Industry Optimism Outweighs Personal Job Security
Industry Optimism Outweighs Personal Job Security
Recent Videos
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Behind the Headlines episode 6
Behind the Headlines episode 5
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Orexo and Abera Partner to Develop Nasal Powder Vaccines

Feliza Mirasol
December 20th 2024
Article

The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novo Nordisk to Establish New Production Facility for Rare Disease Therapies in Denmark with DKK 8.5 Billion Investment

Feliza Mirasol
December 17th 2024
Article

Novo Nordisk will use the DKK 8.5 billion (US$1.2 billion) to build a new modular and flexible production facility in Odense, Denmark, that will produce multiple products for rare diseases.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Novo Nordisk Gains Manufacturing Sites from Novo Holdings and Novavax while EC Approves Catalent Acquisition

Feliza Mirasol
December 11th 2024
Article

The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.

3D printed pills and drugs, future of medicine. 3D Printing Drugs In Pharmacies. Multi-colored, various drugs, pills, capsules. Pharmaceutical medical concept | Image Credit: © irissca - © irissca - stock.adobe.com

Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications

Gary Ritchie;Sharon Flank
December 10th 2024
Article

This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.